Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-26
DOI
10.3389/fmed.2021.642296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps
- (2021) Marcelo Barreto Lopes et al. Scientific Reports
- Ferroterapia en el manejo de la anemia en la enfermedad renal crónica no en diálisis: perspectiva del grupo de anemia de la S.E.N
- (2021) Aleix Cases et al. NEFROLOGIA
- Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
- (2020) Elizabeth Katherine Batchelor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
- (2020) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
- (2020) Iain C. Macdougall et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
- (2020) Marie Evans et al. Clinical Kidney Journal
- Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
- (2020) Tadao Akizawa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MO001ROXADUSTAT FOR THE TREATMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS: A PHASE 3, RANDOMISED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY
- (2020) Jonathan Barratt et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
- (2020) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
- (2020) Piotr Ponikowski et al. LANCET
- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with pre-dialysis chronic kidney disease
- (2019) Monique E. Cho et al. KIDNEY INTERNATIONAL
- Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study
- (2019) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial
- (2019) Francesco Locatelli et al. Clinical Journal of the American Society of Nephrology
- The multifaceted role of iron in renal health and disease
- (2019) Rachel P. L. van Swelm et al. Nature Reviews Nephrology
- Anemia of Inflammation
- (2019) Tomas Ganz NEW ENGLAND JOURNAL OF MEDICINE
- Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
- (2019) Michelle M Y Wong et al. Clinical Kidney Journal
- Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease
- (2019) Ahmed A Awan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The noblesse of kidney physiology
- (2019) Kai-Uwe Eckardt KIDNEY INTERNATIONAL
- Safety of Intravenous Iron in Dialysis
- (2018) Ingrid Hougen et al. Clinical Journal of the American Society of Nephrology
- Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
- (2018) Michele F. Eisenga et al. BMC Nephrology
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
- (2018) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Hypoxia: HIF and PHD Isoform Selectivity
- (2018) Emily R. Watts et al. TRENDS IN MOLECULAR MEDICINE
- Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
- (2018) Guy Rostoker et al. EBioMedicine
- Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
- (2018) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD
- (2017) Guus A. M. Kortman et al. Hemodialysis International
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
- (2017) Gregory D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Microbiota intestinal en la enfermedad renal crónica
- (2017) Secundino Cigarran Guldris et al. NEFROLOGIA
- Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis
- (2017) Richard Holman et al. NEPHROLOGY
- Physiological Effects of Chronic Hypoxia
- (2017) John B. West NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
- (2016) Robert Provenzano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
- (2016) Elke Marsch et al. EUROPEAN HEART JOURNAL
- Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
- (2016) Ewa A. Jankowska et al. EUROPEAN JOURNAL OF HEART FAILURE
- Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
- (2016) Mun Chiang Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
- (2015) Susann Neiser et al. BIOMETALS
- Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron
- (2015) Jorge E. Toblli et al. Heart Lung and Circulation
- Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
- (2015) T. Souma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
- (2015) K. Umanath et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
- (2014) P. Ponikowski et al. EUROPEAN HEART JOURNAL
- The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences
- (2014) IJsbrand T. Klip et al. EUROPEAN JOURNAL OF HEART FAILURE
- HIF Transcription Factors, Inflammation, and Immunity
- (2014) Asis Palazon et al. IMMUNITY
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- The regulation of iron transport
- (2013) David M. Frazer et al. BIOFACTORS
- Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
- (2013) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
- (2013) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
- (2013) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
- (2013) José Portolés et al. BMC Nephrology
- Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
- (2012) Guy Rostoker et al. AMERICAN JOURNAL OF MEDICINE
- Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
- (2012) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Foreword
- (2012) Kidney International Supplements
- Chronic IFN- production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis
- (2011) S. F. Libregts et al. BLOOD
- Endogenous Erythropoietin and the Association with Inflammation and Mortality in Diabetic Chronic Kidney Disease
- (2011) M. Wagner et al. Clinical Journal of the American Society of Nephrology
- A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
- (2011) Markus R. Jahn et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
- (2011) K. L. Johansen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Do two intravenous iron sucrose preparations have the same efficacy?
- (2011) J. Rottembourg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
- (2011) Xiaoqing Pan et al. PLoS One
- Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation
- (2010) Sabine Vogel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
- (2009) Shravanthi R. Gandra et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism
- (2009) E. B. Rankin et al. MOLECULAR AND CELLULAR BIOLOGY
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
- (2008) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease
- (2008) N. D. Vaziri et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)
- (2008) F. Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Epidemiology of Chronic Kidney Disease in Heart Failure
- (2008) Ali Ahmed et al. Heart Failure Clinics
- Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion
- (2007) Elisabeth L. Pagé et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started